Two of these patients, one with NSCLC and one with a neuroendocrine tumor, exhibited persistent memory T cell responses to neoantigens derived from mutations in the oncogenic BRAF and tumor-suppressor PTCH1 genes, respectively. The gene discussed is BRAF; the disease is neoplasm.